RB GLOBAL INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RB GLOBAL INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,127	971	1,170	1,319	1,377	1,417	1,734	3,680	4,284	4,591
Cost of revenue	66.1	79
Gross profit	189	532
Selling, general and administrative	284	323	383	382	410	456	540	744	774	905
Operating income	136	107	185	223	263	241	454	471	761	713
Interest expense	5.56	38.3	44.5	41.3	35.6	37	57.9	214	234	192
Interest income	1.86	3.19			2.34	1.4	7	22	26.2	14.9
Other non-operating income	7.12	8.23	11.9	8.84	5.96	1.9	1.1	4.7	-1.7	-0.1
Pre-tax income	130	77.4	153	191	236	205	406	282	550	536
Income tax	37	2.09	31	41.6	65.5	53.4	86.2	76.4	137	108
Net income to minority interests	1.68	0.28	0.03	0.1	0.26	-0.01	0.1
Net income	91.8	75	121	149	170	152	320	207	413	428
EBITDA	177	160	252	294	338	329	551	824	1,206	1,197
EPS, basic	0.86	0.70	1.12	1.37	1.56	1.38	2.89	1.05	2.03	2.06
EPS, diluted	0.85	0.69	1.11	1.36	1.54	1.36	2.86	1.04	2.01	2.04
Shares, basic (weighted)	107	107	108	109	109	110	111	167	184	185
Shares, diluted (weighted)	107	108	109	110	110	111	112	168	185	187

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	208	268	238	360	279	326	494	576	534	532
Receivables	53	92.1	129	143	135	151	183	732	709	706
Inventory	28.5	38.2	113	65	86.3	102	103	167	122	140
Other current assets	19	27.6	49.1	50.2	27.3	64.3	48.3	91.2	77	108
Total current assets	378	508	604	680	557	762	963	1,814	1,715	1,785
Property, plant and equipment	515	527	487	484	492	449	459	1,201	1,275	1,522
Lease right-of-use assets				116	117	114	123	1,476	1,529	1,546
Goodwill	97.5	671	672	672	841	948	949	4,537	4,512	4,668
Intangible assets	72.3	261	246	233	301	351	323	2,914	2,669	2,465
Other non-current assets	20.2	31.6	29.4	146	148	143	40.4	85.6	98.4	149
Total assets	1,600	2,017	2,052	2,229	2,352	3,593	2,864	12,037	11,807	12,143
Accounts payable	38.7	77.6	93.5	72.9	75.5	85.7	54.3	139	140	142
Accrued liabilities	44.8	55.3	63.7	69.5	99.6	117	119	295	237	348
Deferred revenue							10.5	17.5	20.6	18.9
Short-term debt	23.9	16.9	13.1	18.3	10.4	3.5	4.4	14.2	4.1	51.2
Total current liabilities	253	388	440	501	515	588	795	1,343	1,331	1,618
Long-term debt	596	796	698	627	626	1,734	577	3,062	2,622	2,283
Lease liabilities				111	113	110	112	1,354	1,431	1,457
Other non-current liabilities	38.1	46.8	42	151	153	147	35.4	86.7	97.4	159
Total liabilities	904	1,264	1,216	1,322	1,339	2,522	1,574	6,528	6,091	6,075
Total debt	596	813	711	645	637	1,737	582	3,076	2,626	2,334
Paid-in capital	27.6	41	56.9	52.1	49.2	59.5	85.3	88	95.4
Retained earnings	601	603	648	714	792	840	1,043	919	1,090	1,255
Other comprehensive income	-67.1	-42.5	-56.3	-59.1	-34.3	-56	-85.1	-44	-125	-48.3
Shareholders' equity	687	740	831	902	1,007	1,071	1,290	5,017	5,224	5,571
Minority interests	4.77	5.07	5.07	5.15	5.15	0.39	0.5	2.3	2.3	1.7
Total equity	692	745	836	907	1,012	1,071	1,290	5,019	5,226	5,573
Total liabilities and equity	1,600	2,017	2,052	2,229	2,352	3,593	2,864	12,037	11,807	12,143
Shares outstanding	107	107	109	109	110	111	111	183	185	186

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	93.5	75.3	122	149	170	152	320	206	413	428
Depreciation and amortization	40.9	52.7	66.6	70.5	74.9	87.9	97.2	352	444	483
Stock-based compensation	19.6	19.7	23.4	12.7	16.6	31.3	41.7	55.8	62.4	66
Deferred income tax	-3.36	-17.3	6.24	8.83	9.15	3.9	-0.3	-65.8	-69.2	-54.2
Change in receivables	6.42	-19.2	-43.3	-8.61	22.1	-11.6	-44.1	-36.8	14.8	46.9
Change in inventory	26.6	-8.56	-77.3	44.6	-18.1	-21.9	-7.2	-10.7	26.2	-12.9
Cash from operations	178	148	144	333	258	318	463	544	932	978
Capital expenditures	-18.9	-10.8	-16.9	-13.6	-14.3	-9.8	-32	-228	-167	-259
Acquisitions								-2,779	-8.6	-193
Sales and maturities of investments			6.15		1.7
Cash from investing	-117	-711	-31	-36.1	-277	-214	77.2	-3,108	-302	-553
Debt issued	647	325				1,107	0	3,175	0	275
Debt repaid	-148	-109	-91	-76.3	-13.7	-5.3	-1,131	-654	-454	-577
Stock issued	24.3	9.94	28.5	41.1
Share buybacks	-36.7			-42	-53.2
Dividends paid	-70.5	-72.8	-75.7	-82.5	-91.7	-104	-115	-298	-206	-258
Cash from financing	404	119	-134	-187	-111	961	-1,258	2,676	-646	-461
Exchange rate effect	0	17.2	-4.77	5.17	17	-8.8	-18.8	10.1	-24	22.1
Net change in cash	465	-427	-25.5	115	-113	1,056	-737	122	-39.1	-14
Free cash flow	159	137	127	319	244	308	431	316	765	719
Interest paid	5.79	23.4	39.4	37	32.5	45	38	163	229	189
Income taxes paid	54	28.3	10.4	26.7	43.4	71.2	29.6	180	201	227

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $82.49 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	16.0%	Operating income / revenue.
EBITDA margin	26.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	12.5%	Pre-tax income / revenue.
Net margin	10.0%	Net income / revenue.
FCF margin	12.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.8%	Cash from operations / revenue.
Effective tax rate	20.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.9%	Net income / average total assets.
Return on invested capital (ROIC)	7.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	18.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	10.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	38.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	27.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-6.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	16.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	22.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	29.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	28.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	3.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	10.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	20.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	1.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-10.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	5.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	5.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	28.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	30.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-5.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	18.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	24.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	62.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	40.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	61.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	38.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	18.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	11.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.31x	Current assets / current liabilities.
Quick ratio	0.96x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.36x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.52x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	23.1%	Total debt / total assets.
Liabilities / assets	51.5%	Total liabilities / total assets.
Net debt	$2.36B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.83x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.31x	Operating income / interest expense.
Working capital	$449.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	58.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.76B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.39x	Revenue / average total assets.
Fixed asset turnover	3.01x	Revenue / average property, plant and equipment.
Receivables turnover	5.67x	Revenue / average receivables.
Days sales outstanding	64 days	365 x average receivables / revenue.
FCF conversion	126.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	29.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.59	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$25.94	Revenue / diluted weighted shares.
FCF per share	$3.27	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.61	Cash from operations / diluted weighted shares.
Book value per share	$30.08	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$9.48	Tangible book value / shares outstanding.
Cash per share	$2.84	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$15.42B	Share price x shares outstanding.
Enterprise value	$17.78B	Market cap + total debt - cash - short-term investments.
P/E	31.8x	Market cap / net income. Only when net income is positive.
P/S	3.18x	Market cap / revenue.
P/B	2.77x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	25.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.9x	Market cap / cash from operations, when positive.
EV/Sales	3.67x	Enterprise value / revenue.
EV/EBIT	22.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	29.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.0%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).

What was RB GLOBAL INC.'s revenue in fiscal 2025?

RB GLOBAL INC. reported revenue of $4.59B for fiscal 2025, 7.2% higher than the year before.

Was RB GLOBAL INC. profitable in fiscal 2025?

Yes. Net income was $428.4M, a net margin of 9.3%.

How much free cash flow did RB GLOBAL INC. generate in fiscal 2025?

Cash from operations of $978.2M minus capital expenditures of $259.0M left free cash flow of $719.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RB GLOBAL INC.